Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine- sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1346-1349

  Torre, Donato ^a   Casari, Salvatore ^d   Speranza, Filippo ^a   Donisi, Alessandra ^d   Gregis, Giampietro ^d   Poggio, Antonio ^b   Ranieri, Sergio ^b   Orani, Anna ^c   Angarano, Gioacchino ^d   Chiodo, Francesco ^d   Fiori, Gianpaolo ^a   Carosi, Giampiero ^d  

^a OSPEDALE DI CIRCOLO   (Italy)

^b Regional Hospital   (Italy)

^c Department of Infectious Diseases   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; PYRIMETHAMINE SULFADIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ERUPTION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOXOPLASMOSIS; TREATMENT OUTCOME;

EID: 7144263733     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1346     Document Type: Article

References (26)

1. Canessa, A., V. Del Bono, P. De Leo, N. Piersantelli, and A. Terragna. 1992. Cotrimoxazole therapy of Toxoplasma gondii encephalitis in AIDS patients. Eur. J. Clin. Microbiol. Infect. 11:125-130.
2. Carr, A., B. Tindall, B. J. Brew, D. J. Marriott, J. L. Harkness, R. Penny, and D. A. Cooper. 1992. Low-dose trimethoprim-sulphamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann. Intern. Med. 117: 106-111.
3. Centers for Disease Control and Prevention. 1995. Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. Morbid. Mortal. Weekly Rep. 44:1-34.
4. Chin, T. W. F., A. Vandenbroucke, and I. W. Fong. 1995. Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients. Antimicrob. Agents Chemother. 39:28-33.
5. Cohn, J. A., A. McMeeking, W. Cohen, J. Jacobs, and R. S. Holzman. 1989. Evaluation of the policy of empiric treatment of suspected toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Am. J. Med. 86:521-527.
6. Dannemann, B., J. A. McCutchan, D. Israelski, D. Antoniskis, C. Leport, B. Luft, J. Nussbaum, N. Clumeck, P. Morlat, and J. Chiu. 1992. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin plus sulfadiazine. Ann. Intern. Med. 116:33-43.
7. Dannemann, B. R., D. M. Israelski, and J. S. Remington. 1988. Treatment of toxoplasmic encephalitis with intravenous clindamycin. Arch. Intern. Med. 148:2477-2482.
8. Derouin, F., and C. Chastany. 1989. In vitro effects of folate inhibitors on Toxoplasma gondii. Antimicrob. Agents Chemother. 33:1753-1759.
9. Dudley, M. N., R. E. Levitz, R. Quintiliani, J. M. Hickingbotham, and L. H. Nightgale. 1984. Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges. Antimicrob. Agents Chemother. 26:811-814.
10. Grossman, P. L., and J. S. Remington. 1979. The effect of trimethoprim and sulphamethoxazole on Toxoplasma gondii in vitro and in vivo. Am. J. Trop. Med. Hyg. 28:445-455.
11. Harper, J. S., W. T. London, and J. L. Sever. 1985. Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys. Am. J. Trop. Med. Hyg. 34:55-57.
12. Haverkos, H. W. 1987. Assessment of therapy of toxoplasma encephalitis. The TE study group. Am. J. Med. 82:907-914.
13. Herrera, G., O. Villalta, and K. Visona. 1991. Trimethoprim-sulphamethoxazole treatment encephalitis in AIDS patients, ahstr. WB-2321. In Abstracts of the Seventh International Conference on AIDS.
14. Leport, C., F. Raffi, S. Matheron, C. Katlama, B. Regnier, A. G. Saimot, C. Marche, C. Vedrenne, and J. L. Vilde. 1988. Treatment of central nervous system toxoplasmosis with pyrimethamine-sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous treatment. Am. J. Med. 84:94-100.
15. Levy, R. M., D. E. Bredesen, and M. L. Rosenblum. 1985. Neurological manifestation of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of literature. J. Neurosurg. 62:475-495.
16. Luft, B. J., and J. S. Remington. 1988. Toxoplasmic encephalitis. J. Infect. Dis. 157:1-6.
17. Luft, B. J., and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15:211-222.
18. Michelet, C., F. Raffi, J. M. Besnier, J. M. Chennebault, F. Moulichon, B. Milpied, J. P. Breux, and F. Cartier. 1992. Cotrimoxazole (CMX) versus aerosolized pentamidine (AP) for primary prophylaxis of Pneumocystis carinii (PCP), abstr. B:139. In Abstracts of the Eight International Conference on AIDS.
19. Pedrol, E., J. M. Gonzalez-Clemente, J. M. Gatell, J. Mallolas, J. M. Miro, F. Graus, R. Alvarez, J. M. Mercader, J. Berenguer, and M. T. Jimenez de Auta. 1990. Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy. AIDS 4:511-517.
20. Renold, C., A. Sugar, J. P. Chave, L. Perrin, J. Delavelle, G. Pizzolato, P. Burkhard, V. Gabriel, and B. Hirschel. 1992. Toxoplasma encephalitis. Medicine (Baltimore) 71:224-238.
21. Sattler, F. R., R. Cowan, D. M. Nielsen, and J. Ruskin. 1988. Trimethoprim-sulphamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a prospective, non-crossover study. Ann. Intern. Med. 109:280-287.
22. Solbreux, P., J. Sonnet, and F. Zech. 1990. A retrospective study about the use of cotrimoxazole as diagnostic support and treatment of suspected cerebral toxoplasmosis in AIDS. Acta Clin. Belg. 45:85-96.
23. Svedhem, A., and S. Iwarson. 1979. Cerebrospinal fluid concentrations of trimethoprim during oral and parenteral treatment. J. Antimicrob. Chemother. 5:717-720.
24. Wanke, C., C. U. Tuazon, A. Kovacs, T. Dina, D. O. Davis, N. Barton, D. Katz, M. Lunde, C. Levy, and F. K. Conley. 1987. Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome: diagnosis and response to therapy. Am. J. Trop. Med. Hyg. 36:509-516.
25. Winstanley, P., S. Khoo, S. Szwandt, G. Edwards, E. Wilkins, J. Tija, R. Coker, W. McKane, N. Beeching, and S. Watkin. 1995. Marked variation in pyrimethamine disposition in AIDS patients treated for cerebral toxoplasmosis. J. Antimicrob. Chemother. 36:435-439.
26. Young, L. S., and J. Hindler. 1987. Use of trimethoprim-sulphamethoxazole singly and in combination with other antibiotics in immunocompromised patients. Rev. Infect. Dis. 9(Suppl. 2):S177-S183.